FdaApplication
NDA 021632
Identifiers
- fda_app_no: NDA021632
Properties
| Property | Value |
|---|---|
| applicant_name | VICURON HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2006-02-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERAXIS | ANIDULAFUNGIN | 100MG/VIAL | POWDER;INTRAVENOUS |
| ERAXIS | ANIDULAFUNGIN | 50MG/VIAL | POWDER;INTRAVENOUS |
2 products